| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jan Thon. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. The Journal of neuropsychiatry and clinical neurosciences. vol 19. issue 4. 2008-01-02. PMID:18070865. |
worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. |
2008-01-02 |
2023-08-12 |
Not clear |
| Jürgen Wolf, Firmin Janssen, Henrik Lublin, Raimo K R Salokangas, Hervé Allain, Enrico Smeraldi, Miguel Bernardo, Helen Millar, Miranda Pans, Christine Adelbrecht, Jim Laughton, Christian Werner, Wolfgang Maie. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). Current medical research and opinion. vol 23. issue 10. 2007-12-14. PMID:17706003. |
a prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in europe: broad effectiveness trial with aripiprazole in europe (eu-beta). |
2007-12-14 |
2023-08-12 |
Not clear |
| Jürgen Wolf, Firmin Janssen, Henrik Lublin, Raimo K R Salokangas, Hervé Allain, Enrico Smeraldi, Miguel Bernardo, Helen Millar, Miranda Pans, Christine Adelbrecht, Jim Laughton, Christian Werner, Wolfgang Maie. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). Current medical research and opinion. vol 23. issue 10. 2007-12-14. PMID:17706003. |
to examine the effectiveness of aripiprazole in schizophrenia in a naturalistic setting in 14 european countries. |
2007-12-14 |
2023-08-12 |
Not clear |
| Hui-Ching Huang, Chin-Hung Liu, Tsuo-Hung Lan, Tsung-Ming Hu, Hsien-Jane Chiu, Yu-Chun Wu, Ying Lung Tsen. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 856. issue 1-2. 2007-11-30. PMID:17602901. |
aripiprazole is a novel antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders. |
2007-11-30 |
2023-08-12 |
Not clear |
| Joseph P McEvoy, David G Daniel, William H Carson, Robert D McQuade, Ronald N Marcu. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. Journal of psychiatric research. vol 41. issue 11. 2007-11-30. PMID:17631314. |
a randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. |
2007-11-30 |
2023-08-12 |
Not clear |
| Joseph P McEvoy, David G Daniel, William H Carson, Robert D McQuade, Ronald N Marcu. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. Journal of psychiatric research. vol 41. issue 11. 2007-11-30. PMID:17631314. |
patients requiring inpatient hospitalization for acute exacerbation of schizophrenia were randomized to once-daily aripiprazole 10, 15 or 20 mg/day or placebo for 6 weeks. |
2007-11-30 |
2023-08-12 |
Not clear |
| Joseph P McEvoy, David G Daniel, William H Carson, Robert D McQuade, Ronald N Marcu. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. Journal of psychiatric research. vol 41. issue 11. 2007-11-30. PMID:17631314. |
aripiprazole 10 mg/day is effective and well tolerated for patients experiencing an acute exacerbation of schizophrenia. |
2007-11-30 |
2023-08-12 |
Not clear |
| Sunmee Wee, Zhixia Wang, William L Woolverton, Luigi Pulvirenti, George F Koo. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 32. issue 10. 2007-11-20. PMID:17327886. |
aripiprazole is a dopamine (da) d(2) receptor partial agonist, approved by the food and drug administration (fda) for the treatment of schizophrenia. |
2007-11-20 |
2023-08-12 |
rat |
| Gilbert J L'Italien, Daniel E Casey, Hong J Kan, William H Carson, Ronald N Marcu. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. The Journal of clinical psychiatry. vol 68. issue 10. 2007-11-19. PMID:17960964. |
comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. |
2007-11-19 |
2023-08-12 |
Not clear |
| Gilbert J L'Italien, Daniel E Casey, Hong J Kan, William H Carson, Ronald N Marcu. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. The Journal of clinical psychiatry. vol 68. issue 10. 2007-11-19. PMID:17960964. |
we compared both the rate and incidence of metabolic syndrome among schizophrenia patients (dsm-iv criteria) treated with the atypical antipsychotics aripiprazole or olanzapine or placebo from 4 double-blind, randomized, controlled clinical trials. |
2007-11-19 |
2023-08-12 |
Not clear |
| Jessica W Lea, Steven C Stoner, Jeremy Lafollett. Agitation associated with aripiprazole initiation. Pharmacotherapy. vol 27. issue 9. 2007-11-06. PMID:17723088. |
we describe three patients with long histories of treatment for schizophrenia or schizoaffective disorder in whom conversion to aripiprazole was being attempted. |
2007-11-06 |
2023-08-12 |
Not clear |
| John M Kane, David T Crandall, Ronald N Marcus, James Eudicone, Andrei Pikalov, William H Carson, Wim Swyze. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophrenia research. vol 95. issue 1-3. 2007-10-24. PMID:17644313. |
symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. |
2007-10-24 |
2023-08-12 |
Not clear |
| John M Kane, David T Crandall, Ronald N Marcus, James Eudicone, Andrei Pikalov, William H Carson, Wim Swyze. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophrenia research. vol 95. issue 1-3. 2007-10-24. PMID:17644313. |
this analysis examined symptomatic remission in acutely ill patients with schizophrenia receiving either aripiprazole or haloperidol for one year. |
2007-10-24 |
2023-08-12 |
Not clear |
| Joo-Cheol Shim, Jae-Goo K Shin, Deanna L Kelly, Do-Un Jung, Young-Soo Seo, Kwang-Hyeon Liu, Ji-Hong Shon, Robert R Conle. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. The American journal of psychiatry. vol 164. issue 9. 2007-10-09. PMID:17728426. |
the authors investigated the effect of adjunctive treatment with aripiprazole on hyperprolactinemia and psychopathology in patients with schizophrenia maintained with haloperidol. |
2007-10-09 |
2023-08-12 |
Not clear |
| David Mamo, Ariel Graff, Romina Mizrahi, C M Shammi, Françoise Romeyer, Shitij Kapu. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. The American journal of psychiatry. vol 164. issue 9. 2007-10-09. PMID:17728427. |
differential effects of aripiprazole on d(2), 5-ht(2), and 5-ht(1a) receptor occupancy in patients with schizophrenia: a triple tracer pet study. |
2007-10-09 |
2023-08-12 |
Not clear |
| David Mamo, Ariel Graff, Romina Mizrahi, C M Shammi, Françoise Romeyer, Shitij Kapu. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. The American journal of psychiatry. vol 164. issue 9. 2007-10-09. PMID:17728427. |
the authors conducted a positron emission tomography (pet) study to characterize the simultaneous effects of aripiprazole at the d(2), 5-ht(2), and 5-ht(1a) receptors in patients with schizophrenia or schizoaffective disorder. |
2007-10-09 |
2023-08-12 |
Not clear |
| Gary Sullivan, Markus Bienroth, Martin Jones, Helen Millar, Lawrence Ratna, David Taylo. Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel. Current medical research and opinion. vol 23. issue 7. 2007-09-18. PMID:17588303. |
practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a uk multidisciplinary panel. |
2007-09-18 |
2023-08-12 |
Not clear |
| Gary Sullivan, Markus Bienroth, Martin Jones, Helen Millar, Lawrence Ratna, David Taylo. Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel. Current medical research and opinion. vol 23. issue 7. 2007-09-18. PMID:17588303. |
in accordance with the uk nice guidance on the use of antipsychotic treatment for schizophrenia (2002), aripiprazole may be an appropriate therapeutic option for patients with schizophrenia who are newly diagnosed, in acute relapse or experiencing tolerability problems, adverse metabolic effects or dissatisfaction with their current medication. |
2007-09-18 |
2023-08-12 |
Not clear |
| D Levoyer, D Drapier, G Fadier-Salicé, B Mille. [Clinical impact of aripiprazole in patients suffering from schizophrenia]. L'Encephale. vol 33. issue 3 Pt 1. 2007-09-06. PMID:17675931. |
[clinical impact of aripiprazole in patients suffering from schizophrenia]. |
2007-09-06 |
2023-08-12 |
Not clear |
| D Levoyer, D Drapier, G Fadier-Salicé, B Mille. [Clinical impact of aripiprazole in patients suffering from schizophrenia]. L'Encephale. vol 33. issue 3 Pt 1. 2007-09-06. PMID:17675931. |
in this study, we present seven case reports concerning patients suffering from schizophrenia or schizo-affective disorders, treated by aripiprazole. |
2007-09-06 |
2023-08-12 |
Not clear |